How digital pathology ensures ongoing diagnosis in a time of crisis
Feedbacks from hospitals in France, Canada and Belgium
Contents
Many surgical procedures are being cancelled in this time of crisis, however cancer care must continue. Furthermore, cancer / COVID-19 comorbidities are common and lead to the appearance of new specimens with specific lesions.
Many pathology departments are seeing a decline in their production capacity while they take COVID+ samples and contribute to the analysis of cellular and tissue alterations. In this context, digital pathology would facilitate the sharing of cases and would promote the mobility of the pathologist.
This white paper shows how digital pathology has helped to address the current crisis within pathology departments and to ensure continuity of cancer diagnosis. It deals with the experiences from three hospitals that have been quickly adapting their operation to effectively manage diagnosis in the current context of confinement.
About TRIBVN Healthcare
TRIBVN Healthcare brings digital pathology expertise to the diagnostic imaging market.
The company designs and provides solutions for the acquisition, management, processing and sharing of tissue and cellular diagnostic images. TRIBVN Healthcare is particularly active in oncology, neurological pathologies and metabolism. The company supplies public and private healthcare structures, as well as university and private research centres.
The company has developed real expertise in supporting pathology services in their digital transition.
Source: TRIBVN Healthcare
